TrialDiabetic medicine : a journal of the British Diabetic Association2015

Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double-blind placebo-controlled 102-week trial.

C J Bailey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.